Gupta Suneel 4
4 · Protagonist Therapeutics, Inc · Filed Jan 11, 2024
Insider Transaction Report
Form 4
Gupta Suneel
EVP Clinical Operations
Transactions
- Exercise/Conversion
Common Stock
2024-01-09$7.38/sh+5,000$36,900→ 192,567 total - Sale
Common Stock
2024-01-09$25.00/sh−5,000$125,000→ 187,567 total - Exercise/Conversion
Stock Option (right to buy)
2024-01-09−5,000→ 45,000 totalExercise: $7.38Exp: 2029-01-14→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 25, 2023.
- [F2]These stock options are fully vested.